Nexstim Oyj (OHEL:NXTMH) Total Receivables: €3.15 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OHEL:NXTMH Nexstim Oyj OHEL:NXTMH
61 GF Score
Price €10.80
GF Value €9.38
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Nexstim Oyj Total Receivables?

Nexstim Oyj OHEL:NXTMH +8.22% 61 Total Receivables is €3.15 Mil as of Jun. 2026. GuruFocus rates OHEL:NXTMH with a GF Score™ of 61/100 and a GF Value™ of €9.38 (Modestly Overvalued). The stock has 5 warning signs investors should review.

Nexstim Oyj's Total Receivables for the quarter that ended in Jun. 2026 was €3.15 Mil.

Nexstim Oyj Total Receivables Historical Data

* Premium members only.

The historical data trend for Nexstim Oyj's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nexstim Oyj Total Receivables Chart

Nexstim Oyj Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.85 1.57 3.12 4.03 3.82

Nexstim Oyj Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Total Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.52 4.03 3.32 3.82 3.15
OHEL:NXTMH
61GF Score
Nexstim Oyj OHEL:NXTMH
Total Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nexstim Oyj Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables

Frequently Asked Questions Learn more about Total Receivables →
What does a Total Receivables of €3.15 Mil mean?
Nexstim Oyj (OHEL:NXTMH) has a Total Receivables of €3.15 Mil as of Jun. 2026. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Nexstim Oyj and its competitors.
Is Nexstim Oyj's Total Receivables too high?
Nexstim Oyj's current Total Receivables is €3.15 Mil. Overall, Nexstim Oyj has a GF Score™ of 61/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Nexstim Oyj's Total Receivables compare to ABT and SYK?
Nexstim Oyj's Total Receivables of €3.15 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Receivables for a Medical Devices & Instruments company?
A good Total Receivables depends on the Medical Devices & Instruments industry context. However, Total Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Receivables mean?
A high Total Receivables can signal that a stock is expensive relative to its fundamentals. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Nexstim Oyj and its competitors. Nexstim Oyj's current Total Receivables is €3.15 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nexstim Oyj stock overvalued right now?
Based on GuruFocus' analysis, Nexstim Oyj (OHEL:NXTMH) is currently considered Modestly Overvalued. The stock's GF Value™ is €9.38, compared to a current price of €10.80 — trading 15.1% above its estimated fair value. The current Total Receivables is €3.15 Mil. Nexstim Oyj's overall GF Score™ is 61/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Receivables calculated?
Total Receivables is calculated from a company's financial statements. For Nexstim Oyj (OHEL:NXTMH), the current Total Receivables is €3.15 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Nexstim Oyj (OHEL:NXTMH) Overvalued in 2026?

Based on GuruFocus' analysis, Nexstim Oyj stock appears to be overvalued. The current stock price of €10.80 is trading 15.1% above its estimated GF Value™ of €9.38. GuruFocus considers Nexstim Oyj to be Modestly Overvalued.

Key valuation signals for OHEL:NXTMH:

  • Total Receivables: €3.15 Mil
  • GF Value™: €9.38 vs. price of €10.80 (15.1% above fair value)
  • GF Score™: 61/100 with 5 warning signs

No single metric tells the full story. See the OHEL:NXTMH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Nexstim Oyj Business Description

Other Exchanges 5NX:Germany
Address Elimaenkatu 9 B, Helsinki, FIN, 00510
Nexstim Oyj is a Finnish medical technology company. It has developed a non-invasive brain-stimulation technology for navigated transcranial magnetic stimulation (nTMS), with sophisticated 3D navigation that provides accurate, personalized targeting of TMS to specific brain areas. The company's diagnostic business focuses on commercializing the NBS System 6, an FDA-cleared, CE-marked navigated TMS system for pre-surgical mapping of the brain's speech and motor cortices. Its therapy business sells the NBS System 6 for the treatment of depressive disorder in the United States, and for the treatment of depression, chronic neuropathic pain, and post-operative rehabilitation of motor deficits of the upper limb, in Europe. Geographically, the firm generates maximum revenue from North America.
61GF Score

Get the complete analysis for OHEL:NXTMH

Total Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€10.80
Price
€9.38
GF Value